The gene variant PNPLA3(148M) is a major risk factor for fatty liver, as it promotes steatosis through comparative gene identification 58- (CGI-58-) dependent inhibition of adipose triglyceride lipase (ATGL) during the progression of liver disease. This evidence concerns the gene PNPLA2 and fatty liver disease.